
Glimixia-VM2 Tablet ER
Marketer
Wings Biotech Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimixia-VM2 Tablet ER
Diabex Duo ER tablets are classified as antidiabetic medications, a combination therapy for adult-onset type 2 diabetes. This medication helps regulate blood glucose in diabetic patients. Diabex Duo ER tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is vital, even with seemingly controlled blood sugar, as cessation without medical supervision risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by symptoms such as sweating, dizziness, headache, and tremors. Knowing these symptoms and carrying a quick-acting glucose source (e.g., sugary snacks or juice) is crucial for management. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, swelling, blurred vision, fractures, and upper respiratory infections. Weight gain is also a potential consequence. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (including blood cell counts and liver function) are necessary.
Uses of Glimixia-VM2 Tablet ER
Managing type 2 diabetes
Major Benefits of Glimixia-VM2 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Glimixia-VM2 Tablet ER on an empty stomach.
Common Side effects of Glimixia-VM2 Tablet ER:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimixia-VM2 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glimixia-VM2 Tablet ER. Ingest the tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.
How Glimixia-VM2 Tablet ER works:
Extended-release Glimixia-VM2 tablets contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimixia-VM2 Tablet ER with alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Glimixia-VM2 Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimixia-VM2 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with abnormally low or high blood sugar levels. Refrain from driving if you experience such symptoms.
KidneyUNSAFE
Employing Glimixia-VM2 Tablet ER in individuals with kidney impairment carries a substantial risk and is best avoided. Medical advice is recommended. Furthermore, its use is contraindicated for patients exhibiting severe renal dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimixia-VM2 Tablet ER cautiously, potentially requiring dosage modification. Consult your physician. For those with mild to moderate liver disease, initiation at a low Glimixia-VM2 Tablet ER dose is typical; however, it's contraindicated in severe liver disease.
What if you forget to take Glimixia-VM2 Tablet ER :
Should you forget to take a Glimixia-VM2 Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Glimixia-VM2 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
